Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Metzger

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Journal of Visualized Experiments : Jove|November 21, 2017
Improved Protocol for Chromatin Immunoprecipitation from Mouse Skeletal MuscleShilpy Joshi, Vanessa Ueberschlag-Pitiot, Daniel Metzger, et al.
Molecular & Cellular Oncology|February 22, 2019
Senescence controls prostatic neoplasia driven by Pten lossMaxime Parisotto, Elise Grelet, Rana El Bizri, et al.
Genesis (New York, N.Y. : 2000)|May 3, 2006
Temporal regulation of Cre recombinase activity in neural stem cellsItaru Imayoshi, Toshiyuki Ohtsuka, Daniel Metzger, et al.
Endocrinology|June 23, 2007
Apoptotic extinction of germ cells in testes of Cyp26b1 knockout miceGlenn MacLean, Hui Li, Daniel Metzger, et al.
Genesis (New York, N.Y. : 2000)|March 25, 2005
Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouseMichael Schuler, Faisal Ali, Elisabeth Metzger, et al.
Investigative Ophthalmology & Visual Science|May 1, 2002
Site-specific somatic mutagenesis in the retinal pigment epitheliumMikiro Mori, Daniel Metzger, Jean-Marie Garnier, et al.
Molecular and Cellular Biology|May 30, 2003
TAF10 (TAF(II)30) is necessary for TFIID stability and early embryogenesis in miceWilliam S Mohan, Elisabeth Scheer, Olivia Wendling, et al.
Canadian Journal of Diabetes|May 8, 2022
Toward Building a Provincial Diabetes Registry of Children and Youth Living With Diabetes in British Columbia, CanadaAysha Ayub, Crystal Ng, Elodie Portales-Casamar, et al.
Cancer Research|May 17, 2008
Targeted knockout of BRG1 potentiates lung cancer developmentSelina Glaros, Georgina M Cirrincione, Ariel Palanca, et al.
Cell Death & Disease|March 28, 2026
HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancerDarya Yanushko, Angélique Pichot, Alexandre Vincent, et al.
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Journal of Visualized Experiments : Jove|November 21, 2017
Improved Protocol for Chromatin Immunoprecipitation from Mouse Skeletal MuscleShilpy Joshi, Vanessa Ueberschlag-Pitiot, Daniel Metzger, et al.
Molecular & Cellular Oncology|February 22, 2019
Senescence controls prostatic neoplasia driven by Pten lossMaxime Parisotto, Elise Grelet, Rana El Bizri, et al.
Genesis (New York, N.Y. : 2000)|May 3, 2006
Temporal regulation of Cre recombinase activity in neural stem cellsItaru Imayoshi, Toshiyuki Ohtsuka, Daniel Metzger, et al.
Endocrinology|June 23, 2007
Apoptotic extinction of germ cells in testes of Cyp26b1 knockout miceGlenn MacLean, Hui Li, Daniel Metzger, et al.
Genesis (New York, N.Y. : 2000)|March 25, 2005
Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouseMichael Schuler, Faisal Ali, Elisabeth Metzger, et al.
Investigative Ophthalmology & Visual Science|May 1, 2002
Site-specific somatic mutagenesis in the retinal pigment epitheliumMikiro Mori, Daniel Metzger, Jean-Marie Garnier, et al.
Molecular and Cellular Biology|May 30, 2003
TAF10 (TAF(II)30) is necessary for TFIID stability and early embryogenesis in miceWilliam S Mohan, Elisabeth Scheer, Olivia Wendling, et al.
Canadian Journal of Diabetes|May 8, 2022
Toward Building a Provincial Diabetes Registry of Children and Youth Living With Diabetes in British Columbia, CanadaAysha Ayub, Crystal Ng, Elodie Portales-Casamar, et al.
Cancer Research|May 17, 2008
Targeted knockout of BRG1 potentiates lung cancer developmentSelina Glaros, Georgina M Cirrincione, Ariel Palanca, et al.
Cell Death & Disease|March 28, 2026
HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancerDarya Yanushko, Angélique Pichot, Alexandre Vincent, et al.
Pageof 19